POINT Biopharma Global
$12.5
13
+$0.02+0.16% Tuesday 21:00
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
1.3B
P/E Ratio
0
Dividend Yield
-
Dividend
-
Earnings
22MarExpected
Expected EPS
-0.28
Actual EPS
N/A
Financials
43.38%Profit Margin
Profitable226.58MRevenue
98.29MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow PNT. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate cancer; and PNT2003, a somatostatin-targeted radioligand, which is in Phase III trial for the treatment of neuroendocrine tumors. The company is also developing PNT2001, a next-generation PSMA-targeting product candidate for the treatment of non-metastatic castration sensitive prostate cancer, which is under preclinical studies; and PNT-2004, a fibroblast activation protein-a targeting program being developed for use in multiple tumor types that is under preclinical studies. In addition, it has product candidates being developed on CanSEEK technology sub-licensed from both Bach Biosciences LLC and Avacta Life Sciences Limited. POINT Biopharma Global Inc. was founded in 2019 and is headquartered in Indianapolis, Indiana.
Show more...
CEO
Employees
72
Country
US
ISIN
US7305411099
Listings
0 Comments
Share your thoughts
FAQ
What is POINT Biopharma Global stock price today?▼
The current price of PNT is $12.5 USD — it has increased by +0.16% in the past 24 hours. Watch POINT Biopharma Global stock price performance more closely on the chart.
What is POINT Biopharma Global stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange POINT Biopharma Global stocks are traded under the ticker PNT.
What is POINT Biopharma Global market cap?▼
Today POINT Biopharma Global has the market capitalization of 1.3B
What is POINT Biopharma Global revenue for the last year?▼
POINT Biopharma Global revenue for the last year amounts to 226.58M USD.
What is POINT Biopharma Global net income for the last year?▼
PNT net income for the last year is 98.29M USD.
How many employees does POINT Biopharma Global have?▼
As of April 02, 2026, the company has 72 employees.
In which sector is POINT Biopharma Global located?▼
POINT Biopharma Global operates in the Manufacturing sector.
When did POINT Biopharma Global complete a stock split?▼
POINT Biopharma Global has not had any recent stock splits.